Morgens Waterfall Vintiadis & CO Inc Incyte Corp Transaction History

Morgens Waterfall Vintiadis & CO Inc

  • $118 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$67.18 - $84.11 $1.24 Million - $1.56 Million
18,500 New
18,500 $1.49 Million
Q4 2019

Feb 14, 2020
SELL
$73.04 - $95.72 $1.31 Million - $1.72 Million
-18,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$72.82 - $86.52 $436,919 - $519,120
6,000 Added 50.0%
18,000 $1.34 Million
Q2 2019

Aug 14, 2019
BUY
$73.52 - $88.7 $882,240 - $1.06 Million
12,000 New
12,000 $1.02 Million

Others Institutions Holding INCY

# of Institutions
659
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Morgens Waterfall Vintiadis & CO Inc Portfolio

Follow Morgens Waterfall Vintiadis & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgens Waterfall Vintiadis & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morgens Waterfall Vintiadis & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email